{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-082539","form_type":"8-K","ticker":"INAB","cik":"0001740279","company_name":"IN8BIO, INC.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.048471+00:00","generated_at":"2026-05-15T23:07:04.745906+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"IN8bio director Alan Roemer resigns; Jeremy Graff appointed Interim Chair","bullets":["Alan S. Roemer resigned as director and from Audit and Compensation Committees, effective Feb 28, 2026.","Resignation not due to any disagreement with company, management, or board on operations, policies, or practices.","Board appointed Jeremy Graff, an independent director, as Interim Chair of the Board effective Feb 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-082539","json":"https://secwatch.observer/filing/0001193125-26-082539.json","markdown":"https://secwatch.observer/filing/0001193125-26-082539.md","text":"https://secwatch.observer/filing/0001193125-26-082539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740279/000119312526082539/0001193125-26-082539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740279/000119312526082539/d915471d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:07:04.745906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}